According to the results shown in Figure 6 (panel A), ALT activity decreased significantly after treatment with Esterol10® compared to the control (p < 0.05) and compared to 1 μM RYR (about 7 times more) and to Atorvastatin (about 2 times more) confirming the positive role of Esterol10® in reducing liver damage; this is normally found after chronic treatment with statins, which as known leads to other risk factors, such as hypertension or diabetes mellitus. The gene discussed is GPT; the disease is Hypertension.